News
Kairos Pharma, Ltd. (NYSE American:KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces participation and presentation at the H.C. Wainwright ...
Kairos Pharma reports positive results from phase 2 trial of ENV-105 in advanced prostate cancer: Los Angeles Thursday, July 17, 2025, 15:00 Hrs [IST] Kairos Pharma, Ltd., a clini ...
Kairos Pharma (NYSE American: KAPA) , a clinical-stage biopharma company advancing cancer therapeutics, will participate in the H.C. Wainwright 27th ...
Carotuximab plus Erleada proved safe in the first 10 patients with metastatic castration-resistant prostate cancer dosed on ...
LOS ANGELES, CA, USA I July 15 2025 I Kairos Pharma, Ltd. (NYSE American:KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer ...
Stockhead on MSN8h
Lunch Wrap: ASX waltzes higher as jobless jump sets tempo for rate cutASX bounced back with banks in charge, Aussie jobs data missed, and now all eyes are on a possible August RBA rate cut.
Market Index on MSN4h
Evening Wrap: ASX 200 at fresh all-time highs, RBA rate cut expectations rise on weak unemployment dataThe S&P/ASX 200 closed 77.2 points higher, up 0.90%. In a nutshell: The ASX 200 hit its 10th record high of the year, reversing yesterday's 0.79% dip Market experienced a broad-based rally, with all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback